Synlogic, Inc. (SYBX) stock
SYBXOTCPharmaceutical PreparationsFiscal year ends December 31
$1.07+0.07 (+7.00%)
Close on Oct 19, 2026Market cap $13.29MP/E –Yield –
Synlogic operating income
Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.
Synlogic's operating income for the twelve months ending Sep 30, 2026 was -$5.98M. For fiscal 2025 it was -$4.01M. The highest annual figure on record is -$4.01M in fiscal 2025.
Annual operating income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$4.01M | – |
| FY2024 | Dec 31, 2024 | -$40.95M | – |
| FY2023 | Dec 31, 2023 | -$55.16M | – |
| FY2022 | Dec 31, 2022 | -$67.42M | – |
| FY2021 | Dec 31, 2021 | -$60.77M | – |
| FY2020 | Dec 31, 2020 | -$60.47M | – |
| FY2019 | Dec 31, 2019 | -$54.41M | – |
| FY2018 | Dec 31, 2018 | -$51.23M | – |
| FY2017 | Dec 31, 2017 | -$40.82M | – |
| FY2016 | Dec 31, 2016 | -$20.96M | – |
Quarterly operating income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | -$2.30M | – |
| Q2 FY2026 | Jun 30, 2026 | -$1.01M | – |
| Q1 FY2026 | Mar 31, 2026 | -$1.32M | – |
| Q4 FY2025 | Dec 31, 2025 | -$1.34M | – |
| Q3 FY2025 | Sep 30, 2025 | -$991.00K | – |
| Q2 FY2025 | Jun 30, 2025 | -$777.00K | -285.4% |
| Q1 FY2025 | Mar 31, 2025 | -$898.00K | – |
| Q4 FY2024 | Dec 31, 2024 | -$1.78M | – |
| Q3 FY2024 | Sep 30, 2024 | -$748.00K | – |
| Q2 FY2024 | Jun 30, 2024 | $419.00K | – |
| Q1 FY2024 | Mar 31, 2024 | -$38.85M | – |
| Q4 FY2023 | Dec 31, 2023 | -$10.64M | – |
| Q3 FY2023 | Sep 30, 2023 | -$12.62M | – |
| Q2 FY2023 | Jun 30, 2023 | -$15.65M | – |
| Q1 FY2023 | Mar 31, 2023 | -$16.24M | – |
| Q4 FY2022 | Dec 31, 2022 | -$17.30M | – |
| Q3 FY2022 | Sep 30, 2022 | -$18.33M | – |
| Q2 FY2022 | Jun 30, 2022 | -$16.02M | – |
| Q1 FY2022 | Mar 31, 2022 | -$15.77M | – |
| Q4 FY2021 | Dec 31, 2021 | -$15.15M | – |
| Q3 FY2021 | Sep 30, 2021 | -$16.06M | – |
| Q2 FY2021 | Jun 30, 2021 | -$14.53M | – |
| Q1 FY2021 | Mar 31, 2021 | -$15.03M | – |
| Q4 FY2020 | Dec 31, 2020 | -$14.69M | – |
| Q3 FY2020 | Sep 30, 2020 | -$13.44M | – |
| Q2 FY2020 | Jun 30, 2020 | -$15.94M | – |
| Q1 FY2020 | Mar 31, 2020 | -$16.40M | – |
| Q4 FY2019 | Dec 31, 2019 | -$13.48M | – |
| Q3 FY2019 | Sep 30, 2019 | -$14.14M | – |
| Q2 FY2019 | Jun 30, 2019 | -$13.10M | – |
| Q1 FY2019 | Mar 31, 2019 | -$13.70M | – |
| Q4 FY2018 | Dec 31, 2018 | -$12.71M | – |
| Q3 FY2018 | Sep 30, 2018 | -$11.53M | – |
| Q2 FY2018 | Jun 30, 2018 | -$15.35M | – |
| Q1 FY2018 | Mar 31, 2018 | -$11.64M | – |
| Q4 FY2017 | Dec 31, 2017 | -$11.92M | – |
| Q3 FY2017 | Sep 30, 2017 | -$12.08M | – |
| Q2 FY2017 | Jun 30, 2017 | -$9.46M | – |
| Q1 FY2017 | Mar 31, 2017 | -$7.37M | – |
| Q4 FY2016 | Dec 31, 2016 | -$6.86M | – |
See a number that looks wrong?